What Changed at Iambic Therapeutics

Every material change AI Health Index has tracked at Iambic Therapeutics: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact
Type
1 entry
Showing changes for Iambic Therapeutics only.Show the full log

September 2026

I
Iambic Therapeutics
Sep 21, 2026
HighVerified
Model / architecture

Iambic released Enchant v3, the third generation of the multimodal transformer behind its drug discovery platform. Iambic states the model has 41 billion parameters, was pretrained on 4.5 trillion tokens, and covers more than 6,000 molecular properties across 16 biomedical data modalities using a mixture of experts architecture. Iambic says it will be used on internal and partner programs.

Our read

Enchant v3 is the model partners get when they work with Iambic, so its prediction accuracy is the thing being bought. Iambic says scaling has held across three generations, including on endpoints with sparse data. Ask for the benchmark results in the Enchant v3 report and how they hold on targets with little training data.

Related axis: Model and Technology TransparencyVendor announcementView source